News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
258,269 Results
Type
Article (13804)
Company Profile (289)
Press Release (244176)
Section
Business (79288)
Career Advice (148)
Deals (13172)
Drug Delivery (31)
Drug Development (50249)
Employer Resources (31)
FDA (5665)
Job Trends (5106)
News (143993)
Policy (10013)
Tag
Academia (901)
Alliances (21428)
Alzheimer's disease (709)
Approvals (5630)
Artificial intelligence (56)
Bankruptcy (97)
Best Places to Work (4432)
Biotechnology (238)
Breast cancer (47)
Cancer (527)
Career advice (129)
CAR-T (40)
Cell therapy (140)
Clinical research (39464)
Collaboration (183)
Compensation (76)
COVID-19 (996)
C-suite (46)
Cystic fibrosis (61)
Data (542)
Diabetes (56)
Diagnostics (1184)
Earnings (28446)
Events (46289)
Executive appointments (140)
FDA (5880)
Funding (182)
Gene editing (46)
Gene therapy (121)
GLP-1 (281)
Government (1061)
Healthcare (6523)
Infectious disease (1021)
Inflammatory bowel disease (85)
IPO (7158)
Job creations (859)
Job search strategy (125)
Layoffs (179)
Legal (1372)
Lung cancer (96)
Manufacturing (61)
Medical device (2538)
Medtech (2539)
Mergers & acquisitions (6072)
Metabolic disorders (184)
Neuroscience (877)
NextGen Class of 2024 (1989)
Non-profit (840)
Northern California (717)
Obesity (107)
Opinion (88)
Parkinson's disease (54)
Patents (41)
People (24854)
Pharmaceutical (46)
Phase I (13867)
Phase II (18348)
Phase III (11658)
Pipeline (124)
Postmarket research (846)
Preclinical (5856)
Radiopharmaceuticals (203)
Rare diseases (136)
Real estate (1409)
Regulatory (8137)
Research institute (930)
Southern California (671)
Startups (1963)
United States (6062)
Vaccines (148)
Weight loss (67)
Date
Last 7 days (423)
Last 30 days (1614)
Last 365 days (20861)
2024 (16995)
2023 (22412)
2022 (26822)
2021 (27806)
2020 (23357)
2019 (16224)
2018 (11740)
2017 (13746)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (146)
Arizona (41)
Asia (16735)
Australia (2811)
California (1623)
Canada (605)
China (125)
Colorado (59)
Connecticut (61)
Europe (35982)
Florida (173)
Georgia (44)
Illinois (100)
Indiana (49)
Kansas (54)
Maryland (241)
Massachusetts (1336)
Michigan (45)
Minnesota (80)
New Jersey (438)
New York (500)
North Carolina (369)
Northern California (717)
Ohio (68)
Pennsylvania (355)
South America (207)
Southern California (671)
Texas (160)
Washington State (177)
258,269 Results for "tmunity therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Kite Completes Acquisition of Tmunity
Kite, a Gilead Company (NASDAQ: GILD), today announced the completion of the previously announced transaction to acquire Tmunity Therapeutics (Tmunity), a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies.
February 22, 2023
·
4 min read
Deals
Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer
Kite today announced that the companies have signed an agreement in which Kite will acquire Tmunity, a clinical-stage, private biotech company focused on next-generation CAR T-therapies and technologies.
December 20, 2022
·
8 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Business
Avenzo Therapeutics Announces Appointment of Garry Nicholson to Board of Directors as Independent Director
October 1, 2024
·
2 min read
Press Releases
NeuroEM Therapeutics(R) Accepted into StartUp Health’s Alzheimer’s Moonshot Community(TM)
September 19, 2024
·
4 min read
Layoffs
Relay Therapeutics to Lay Off 10% of Workforce
Relay Therapeutics is cutting its workforce to help streamline its research organization as it looks to complete its first large-scale, pivotal clinical trial.
October 4, 2024
·
1 min read
·
Angela Gabriel
Layoffs
Sage Therapeutics Will Lay Off 33% of Employees, Including Over Half of R&D
As part of a strategic reorganization intended in part to support the ongoing launch of its postpartum depression drug, Sage Therapeutics is cutting more than 165 employees.
October 17, 2024
·
2 min read
·
Angela Gabriel
Business
TScan Therapeutics Announces Updates to its Board of Directors - June 14, 2024
TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment of patients with cancer, announced changes to its Board of Directors.
June 14, 2024
·
6 min read
Press Releases
Valerio Therapeutics Acquires Emglev Therapeutics, a Single-Domain Antibody-Based Therapeutics Company
September 30, 2024
·
8 min read
Pharm Country
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Aquestive Therapeutics, Inc. announced that the Aquestive management team will participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism and host investor meetings on July 9, 2024.
June 27, 2024
·
2 min read
1 of 25,827
Next
